Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Iscience|December 17, 2024
Utilizing machine learning to optimize agricultural inputs for improved rice production benefitsTao Liu, Xiafei Li, Xinrui Li, et al.
Frontiers in Plant Science|August 23, 2024
Enhancing rice ecological production: synergistic effects of wheat-straw decomposition and microbial agents on soil health and yieldYanfang Wen, Yangming Ma, Ziniu Wu, et al.
Frontiers in Plant Science|June 19, 2026
The relationship of rice yield and quality with the utilization of temperature and light resources in regions at different altitudesRuijie Li, Yongheng Luo, Tao Lu, et al.
Food Chemistry|December 25, 2025
Improving rice quality by enhancing key amylose and amylopectin and their complexation with fatty acidsTao Liu, Xinrui Li, Jiayue Wang, et al.
Frontiers in Plant Science|May 27, 2024
Effects of urea topdressing time on yield, nitrogen utilization, and quality of mechanical direct-seeding hybrid indica rice under slow-mixed fertilizer base applicationYongjian Sun, Mengwen Xing, Ziting He, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|March 7, 2022
Exosomes-Loaded Electroconductive Hydrogel Synergistically Promotes Tissue Repair after Spinal Cord Injury via Immunoregulation and Enhancement of Myelinated Axon GrowthLei Fan, Can Liu, Xiuxing Chen, et al.
Foods (Basel, Switzerland)|June 26, 2026
Impacts of In Situ Wheat Straw Incorporation Methods on Cadmium Behavior in Soil-Rice SystemsLeilei Li, Zhengbo Peng, Cheng Wang, et al.
International Journal of Molecular Sciences|June 28, 2023
Ectopic Expression of a Maize Gene ZmDUF1645 in Rice Increases Grain Length and Yield, but Reduces Drought Stress ToleranceYaqi Li, Wei Wang, Changqiong Hu, et al.
The Oncologist|August 10, 2019
Phase Ib Study of Combination Therapy with MEK Inhibitor Binimetinib and Phosphatidylinositol 3-Kinase Inhibitor Buparlisib in Patients with Advanced Solid Tumors with RAS/RAF AlterationsAditya Bardia, Mrinal Gounder, Jordi Rodon, et al.
Investigational New Drugs|May 16, 2020
A phase 1b study of the MET inhibitor capmatinib combined with cetuximab in patients with MET-positive colorectal cancer who had progressed following anti-EGFR monoclonal antibody treatmentJean-Pierre Delord, Guillem Argilés, Jerôme Fayette, et al.
Pageof 7